Jushi Holdings Inc.
JUSH · OTCMCIK 1909747fmd_0K76DR7C8HWGR7RMAS2AD9KRBHManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 24 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 81 | 209 | 284 | 269 | 258 | 263 |
| Cost of revenue | 42 | 126 | 189 | 153 | 139 | 149 |
| Net interest income | (15) | (31) | (46) | (37) | – | – |
| Gross profit | 38 | 83 | 95 | 116 | 118 | 114 |
| Realized investment gains (losses) | (2) | 1 | (1) | (1) | (0) | 0 |
| Selling, general and administrative | 55 | 113 | 156 | 110 | 107 | 109 |
| Compensation and benefits | 22 | 58 | 71 | 56 | 56 | 57 |
| Total operating expenses | 55 | 119 | 316 | 119 | 107 | 109 |
| Operating income | (17) | (36) | (220) | (3) | 11 | 5 |
| Interest expense | 16 | 31 | 46 | 37 | 38 | 41 |
| Interest and investment income | 0 | 0 | 0 | 0 | 1 | 0 |
| Other non-operating income (expense) | (185) | 83 | 26 | (30) | (28) | (38) |
| Income tax expense | 11 | 30 | 8 | 32 | 32 | 35 |
| Net income | (211) | 20 | (202) | (65) | (49) | (69) |
| Net income to common shareholders | (211) | (84) | (294) | (65) | – | – |